The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden-Reference-Cited by-同舟云学术

The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden

Published:2018-08-29 Issue:1 Volume:20 Page:
ISSN:1478-6362
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Kapetanovic Meliha C.,Nilsson Peter,Turesson Carl,Englund Martin,Dalbeth Nicola,Jacobsson Lennart

Funder

Kockska stiftelse Sweden

SUS stiftelser och donationsfonder Sweden

Stiftelsen Professor Nanna Svartz Fond

Reumatikerfonden

Alfred Österlunds Stiftelse

Anna Greta Crafoords stiftelse SE

Inger Bendix stiftelse (SE)

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13075-018-1697-6.pdf

Reference42 articles.

1. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the normative aging study. Am J Med. 1987;82:421–6.

2. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG. Gout epidemiology: results from the UK general practice research database 1990-1999. Ann Rheum Dis. 2005;64(2):267–72.

3. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and nutrition examination survey 2007-2008. Arthritis Rheum. 2011;63(10):3136–41.

4. Lin KC, Lin HY, Chou P. Community based epidemiological study on hyperuricemia and gout in kin-Hu. Kinmen J Rheumatol. 2000;27(4):1045–50.

5. Smith E, Hoy D, Cross M, Merriman TR, Vos T, Buchbinder R, Woolf A, March L. The global burden of gout: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(8):1470–6.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arthropathies microcristallines : incidence, prévalence et facteurs de risque;Revue du Rhumatisme;2024-07

2. Sodium-Glucose Cotransporter-2 Inhibitors vs Sulfonylureas for Gout Prevention Among Patients With Type 2 Diabetes Receiving Metformin;JAMA Internal Medicine;2024-06-01

3. Associations between Sleep-Disordered Breathing and Serum Uric Acid and Their Sex Differences: The Nagahama Study;Nutrients;2023-09-30

4. Comparative Effectiveness of Sodium–Glucose Cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-Primary Emergency Department Visits and Hospitalizations;Annals of Internal Medicine;2023-08

5. Asymptomatic hyperuricemia: obvious, controversial, hypothetical;Profilakticheskaya meditsina;2023